当前位置:首页 - 行情中心 - 三生国健(688336) - 财务分析 - 利润表

三生国健

(688336)

  

流通市值:105.47亿  总市值:105.47亿
流通股本:6.17亿   总股本:6.17亿

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入266,895,0001,014,034,317.69730,604,269.06477,808,271.19
营业收入266,895,0001,014,034,317.69730,604,269.06477,808,271.19
二、营业总成本169,625,400791,662,901.01573,320,875.34395,817,474.39
营业成本61,180,200224,104,872.47168,228,485.5119,129,741.34
税金及附加2,144,1009,374,342.066,839,841.974,595,165.25
销售费用51,385,400251,787,601.35194,865,702.29126,181,410.29
管理费用16,918,50063,103,030.2752,125,348.834,581,661.49
研发费用53,162,300282,303,603.88179,648,937.99129,705,413.53
财务费用-15,165,100-39,010,549.02-28,387,441.21-18,375,917.51
其中:利息费用302,8001,402,188.721,095,902.78782,847.23
其中:利息收入14,941,90039,640,272.0527,755,620.6416,859,219.46
加:公允价值变动收益5,408,00019,399,484.6213,743,429.459,653,123.73
加:投资收益-3,438,800-16,399,243.89-12,814,911.96-8,544,911.96
资产处置收益-56,391,358.48-1,422,710.9-1,379,946.57
资产减值损失(新)-72,0001,063,502.43-456,264.4-396,104
信用减值损失(新)-389,9006,803,448.626,815,968.186,630,399.6
其他收益5,090,20028,583,998.5411,271,306.87,270,539.41
营业利润平衡项目0000
四、营业利润103,867,100318,213,965.48174,420,210.8995,223,897.01
减:营业外支出4,000,7007,579,832.055,161,067.591,706,958.23
利润总额平衡项目0000
五、利润总额99,866,400310,634,133.43169,259,143.393,516,938.78
减:所得税费用11,105,20027,274,171.5314,358,935.54,359,576.97
六、净利润88,761,200283,359,961.9154,900,207.889,157,361.81
持续经营净利润88,761,200283,359,961.9154,900,207.889,157,361.81
归属于母公司股东的净利润91,119,100294,614,423.23163,916,132.7494,754,571.46
少数股东损益-2,357,900-11,254,461.33-9,015,924.94-5,597,209.65
(一)基本每股收益0.150.480.270.15
(二)稀释每股收益0.150.480.270.15
八、其他综合收益930,0001,956,456.74,547,987.235,136,220.3
归属于母公司股东的其他综合收益930,0001,956,456.74,547,987.235,136,220.3
九、综合收益总额89,691,300285,316,418.6159,448,195.0394,293,582.11
归属于母公司股东的综合收益总额92,049,100296,570,879.93168,464,119.9799,890,791.76
归属于少数股东的综合收益总额-2,357,800-11,254,461.33-9,015,924.94-5,597,209.65
公告日期2024-04-262024-03-212023-10-192023-08-25
审计意见(境内)标准无保留意见
TOP↑